Prescribing Information

Download the complete Prescribing Information.

This document is provided in Adobe® Reader® format (PDF). In order to view PDF documents, you must have the Adobe® Reader® software installed on your computer. If you do not have the Acrobat Reader, download it from the

Adobe Web site

HemophiliaMoms.com

Important Safety Information for Helixate^®FS

Helixate^® FS, Antihemophilic Factor (Recombinant), is a recombinant factor VIII treatment indicated for the treatment of hemophilia A.

The most frequently reported adverse events were local injection-site reactions, dizziness, and rash.

Known intolerance or allergic reactions to constituents of the preparation is a contraindication to the use of Helixate^® FS. Known hypersensitivity to mouse or hamster protein may be a contraindication to the use of Helixate^® FS.

Please see the full prescribing information.